Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a handheld ultrasound help clinics spot heart failure sooner?

NCT ID NCT07828834

Diagnosis Sponsor: Corewell Health West Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

Researchers at Corewell Health West are testing whether medical assistants can use a handheld ultrasound device to estimate heart pumping function in people with new heart symptoms. The trial enrolls up to 100 adults at rural outpatient clinics who have not had a recent echocardiogram. Half receive the ultrasound scan during their visit, and half continue with standard care. The goal is to see if this approach is practical and whether it helps diagnose reduced-pump heart failure and start treatment faster.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
point-of-care ultrasound, a handheld device that medical assistants use to estimate heart pumping function
What this could lead to
If it works, handheld ultrasound in rural clinics could help doctors spot reduced-pump heart failure sooner and start guideline-directed treatment faster.
What could go wrong
This is a small pilot study at one center, so it may not show a clear benefit or translate to other clinics. Training medical assistants to read heart function accurately is a real challenge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient Inclusion/Exclusion Criteria Inclusion Criteria: * 18 years of age or older at time of consent * Presenting to an enrolled CH study site with visit type: * A. PCP - New onset cardiac complaints (e.g., dyspnea on exertion, orthopnea, etc) * B. Cardiology - New Patient * Weight ≥ 40kg Exclusion Criteria: * Documented echocardiogram in the past 3 years * History of cardiac surgery or congenital heart disease * O2-dependent pulmonary disease * BMI ≥40kg/m2 * Pregnancy * Non-native English speakers who have limited spoken or written understanding of the English language to be able to consent or complete surveys in English * Cognitively impaired individuals with a legally authorized representative or guardian Staff Participant Inclusion/Exclusion Criteria Inclusion: * 18 years of age or older at time of verbal consent * Employed to work at a CH clinic where patient enrollment is planned Exclusion: * Deemed inappropriate or ineligible for any reason at PI discretion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure with reduced ejection fraction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure with reduced ejection fraction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Corewell Health West

    Grand Rapids, Michigan, 49503, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.